SIA
AGN

Stancorp Investment Advisers’s Allergan plc AGN Stock Holding History

Stancorp Investment Advisers’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$1.28M Sell
4,286
-685
-14% -$195K 0.6% 47
2014
Q4 		$1.28M Buy
+4,971
New +$1.24M 0.59% 50

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Stancorp Investment Advisers's AGN Position: Q1 2015 in Review

Stancorp Investment Advisers reduced its Allergan plc (AGN) stake by 14% in Q1 2015, selling an estimated $195K and leaving 4,286 shares worth $1.28M. The position accounts for 0.6% of the portfolio, ranked #47.

Stancorp Investment Advisers first reported a position in AGN in Q4 2014 and has held it in 2 quarters since. The position peaked at $1.28M in Q4 2014. 1,089 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Stancorp Investment Advisers held 4,286 shares of Allergan plc worth $1.28M as of Q1 2015.
  • Stancorp Investment Advisers sold 685 Allergan plc shares in Q1 2015, an estimated $195K.
  • Allergan plc made up 0.6% of Stancorp Investment Advisers's portfolio in Q1 2015, its #47 holding.
  • Stancorp Investment Advisers first reported a position in Allergan plc in Q4 2014 and has held it in 2 quarters since.
  • Stancorp Investment Advisers's Allergan plc position peaked at $1.28M in Q4 2014.
  • 1,089 funds tracked by Wall St. Rank held Allergan plc as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.